Preferences help
enabled [disable] Abstract
Number of results
2019 | 124 | 2 | 264-278
Article title

Molecular docking and pharmacokinetics study for selected leaf phytochemicals from Carica papaya Linn. against dengue virus protein, NS2B/NS3 protease

Title variants
Languages of publication
The Culex mosquito-transmitted dengue virus (DENV) under genus Flavivirus, a member of Flaviviridae family, cause dengue fever worldwide also in many parts of India. At present, antidengue drugs or therapies from natural products of the leaf extracts of papaya plant, Carica papaya Linn. is interesting research. The present computational prediction was attempted to detect inhibitory potential of established ten common phytoconstituents of leaf of C. papaya against the protein of dengue virus (NS2B/NS3 protease) through molecular docking and pharmacokinetic study. The NS2B/NS3 protease (receptor) was obtained (PDB: 2FOM) from European Protein databank. The phytochemicals ten numbers were used as ligands in this predictive study. The information of these phytochemicals was obtained from PubChem database. The software viz. PyRx (Version 0.8) and ADMET-SAR online tool were used for the study of molecular docking as well as pharmacokinetics study. The present results indicate that natural products from C. papaya interacts with different residues of dengue virus protein having favourable binding energy and suitable drug likeness. It was observed that apigenin and luteolin favourable binding energy (-7.7 Kcal/mol) but luteolin may be suitable lead compound due to inhibitory effect on target receptor as well as ADME efficacy through pharmacokinetics evaluation. In conclusion, it was obtained through faster screening by using software that phytoconstitent luteolin from C. papaya may use future drug as lead compound for the prevention of dengue fever. It is suggested that functional assay (in vivo and in vitro assay) should be carried out for the validation of present predictive data.
Physical description
  • Department of Botany, Serampore College, University of Calcutta, William Carey Road, Hooghly, West Bengal, India
  • Department of Botany, Serampore College, University of Calcutta, William Carey Road, Hooghly, West Bengal, India
  • [1] Recker M, Vannice K, Hombach J. Jit M, Simmons CP, Assessing dengue vaccination impact: Model challenges and future directions. Vaccine 34(38) (2016) 4461-4465
  • [2] Low JGH, Ooi EE, Vasudevan SG, Current status of dengue therapeutics research and development. J Infect Dis. 215(Suppl 2) (2017) S96-102
  • [3] Srivarangkul P, Yuttithamnon W, Suroengrit A, Pankaew S, Hengphasatporn K, Rungrotmongkol T, et al. A novel flavanone derivative inhibits dengue virus fusion and infectivity. Antiviral Res. 151 (2018) 27-38
  • [4] Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 8 (2010) S7-16
  • [5] Elahi M, Islam MM, Noguchi K, Yohda M, Toh H, Kuroda Y, Computational prediction and experimental characterization of a “size switch type repacking” during the evolution of dengue envelope protein domain III (ED3). Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1884(3) (2014) 585-592
  • [6] Mirza SB, Salmas RE, Fatmi MQ, Durdagi S, Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study. Journal of Molecular Graphics and Modelling 66 (2016) 99-107
  • [7] Mukhopadhyay S, Kuhn RJ, Rossmann MG, A structural perspective of the flavivirus life cycle. Nat Rev Microbiol. 3 (2005) 13-22
  • [8] Luo D, Xu T, Watson RP, Scherer-Becker D, Sampath A, Jahnke W, et al. Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. The EMBO Journal 27 (2008) 3209-3219
  • [9] Pereira R, Kunh JR, Structural proteomics of dengue virus. Curr Opin Microbiol. 11 (2008) 369
  • [10] [10] Rothwell C, Lebreton A, Young Ng C, Lim JY, Liu W, Vasudevan S, et al. Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389 (2009) 8-19
  • [11] Deng J, Li N, Liu H, Zuo Z, Liew OW, Xu W, et al. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping. J Med Chem. 55(14) (2012) 6278-6293
  • [12] Suganya J, Mahendran R, Insilico QSAR and molecular docking studies of selected medicinal plant compounds against NS5 & NS3 protein of dengue virus: a comparative approach. Int J Pharm Bio Sci. 7(3) (2016) (B) 1135-1144
  • [13] de Almeida H, Bastos IMD, Ribeiro BM, Maigret B, Santana JM, New binding site conformations of the Dengue Virus NS3 protease accessed by molecular dynamics simulation. PLoS ONE 8(8) (2013) e72402. doi:10.1371/journal.pone.0072402
  • [14] Schüller A, Yin Z, Brian Chia CS, Doan DNP, Kim H-K et al. (2011). Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease. Antiviral Res 92: 96-101
  • [15] Aravind, G., Bhowmik, D., Duraivel, S, Harish, G. 2013. Traditional and medicinal uses of Carica papaya. Journal of Medicinal Plants Studies 1(1): 7-15
  • [16] Miean, K.H., Mohamed, S., 2001. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem. 49, 3106-3112
  • [17] Canini A, Alesiani D, D'Arcangelo G, Tagliatesta P, Gas chromatography-mass spectrometry analysis of phenolic compounds from Carica papaya L. leaf. J Food Compos Anal. 20 (2007) 584-590
  • [18] Lim TK, Carica papaya. In: Edible medicinal and non-medicinal plants. Springer 1 (2012) 693-717
  • [19] Senthilvel P, Lavanya P, Kumar KM, Swetha R, Anitha P, Bag S, et al. Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly. Bioinformation 9(18) (2013) 889-895
  • [20] Yogiraj V, Goyal PK, Chauhan CS, Goyal A, Vyas B, Carica papaya Linn: An overview. International Journal of Herbal Medicine 2(5) (2014) 01-08
  • [21] Ahmad N, Fazal H, Ayaz M, Abbasi BH, Mohammad I, Fazal L, Dengue fever treatment with Carica papaya leaves extracts. Asian Pac J Trop Biomed. 1(4) (2011) 330-333
  • [22] Lionta E, Spyrou G, Vassilatis DK, Cournia Z. Structure-based virtual screening for drug discovery: Principles, applications and recent advances. Curr Top Med Chem. 2014; 14:1923-1938
  • [23] Kontoyianni M. Docking and virtual screening in drug discovery. In: Lazar I, Kontoyianni M, Lazar A. (editors). Proteomics for drug discovery: Methods in molecular biology. Vol. 1647 New York: Humana Press, 255-266 (2017)
  • [24] Vyas, V., Jain, A., Jain, A. and Gupta, A. Virtual Screening: A Fast Tool for Drug Design. Sci Pharm. 2008; 76: 333-360
  • [25] López-Vallejo F, Caulfield T, Martínez-Mayorga K, Giulianotti MA, Houghten RA, Nefzi A, et al. Integrating virtual screening and combinatorial chemistry for accelerated drug discovery. Comb Chem High Throughput Screen. 14 (2011) 475-487
  • [26] Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46 (1-3) (2012) 3-26
  • [27] Ferreira LG, dos Santos RN, Oliva G, Andricopulo AD, Molecular docking and structure-based drug design strategies. Molecules 20 (2015) 13384-13421
  • [28] Daina A, Michielin O, Zoete V, SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules. Sci Rep. 7 (2017) 42717. doi: 10.1038/srep42717
  • [29] Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, et al. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol. 13 (2006) 372-373
  • [30] Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 19 (1998) 1639-1662
  • [31] Trott O, Olson AJ, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem. 31 (2010) 455-461
  • [32] Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, et al. SAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 52 (11) (2012) 3099-3105
  • [33] Wu H, Bock S, Snitko M, Berger T, Weidner T, Holloway S, et al. Novel dengue virus NS2B/NS3 protease inhibitors. Antimicrob Agents Chemother 59 (2015) 1100-1109
  • [34] de Oliveira SA, da Silva ML, Flávia Oliveira AFCS, da Silva CC, Teixeira RR, De Paula SO, NS3 and NS5 proteins: Important targets for anti-dengue drug design. Journal of the Brazilian Chemical Society 25(10) (2014). 1759-1769
  • [35] Mucsi I, Pragai BM, Inhibition of virus multiplication and alteration of cyclic AMP level in cell cultures by flavonoids. Experientia 41 (1985) 930-931
  • [36] Chappell KJ, Stoermer MJ, Fairlie DP, Young PR, West Nile Virus NS2B/NS3 protease as an antiviral target. Current Medicinal Chemistry 15 (2008) 2771-2784
  • [37] Zandi K, Teoh B-T, Sam S-S, Wong P-F, Mustafa MR, AbuBakar S, Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virology Journal 8 (2011) 560. doi:10.1186/1743-422X-8-560
  • [38] Kim YM, Gayen S, Kang C-B, Joy J, Huang Q, Chen AS, et al. NMR Analysis of a novel enzymatically active unlinked Dengue NS2B-NS3 protease complex. The Journal of Biological Chemistry 288 (2013) 12891-12900
  • [39] Mishra P, Evaluation of Phytochemical compounds from Carica papaya as Potential drugs against Dengue virus: An In silico approach. MSc. Thesis, Department of Bioinformatics Centre for post graduate studies Orissa University of Agriculture and Technology, Bhubaneswar, Odisha (2016).
  • [40] Yildiz M, Ghosh S, Bell JA, Sherman W, Hardy JA, Allosteric inhibition of the NS2B-NS3 protease from dengue virus. ACS Chem Biol. 8(12) (2013) 2744-2752
  • [41] Schöne T, Grimm LL, Sakai N, Zhang L, Hilgenfeld R, Peters T. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease. Antiviral Res. 146 (2017) 174-183
  • [42] Silva-Junior E, Schirmeister T, Araújo-Júnior J, Recent advances in inhibitors of flavivirus NS2B-NS3 protease from Dengue, Zika, and West Nile viruses. In: Vector-Borne Diseases and Treatment. Chapter 1 (2018).
  • [43] Paramashivam SK, Elayaperumal K, Natarajan BB, Ramamoorthy MD, Balasubramanian S, Dhiraviam KN, In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases. Bioinformation 11(2) (2015) 073-084
  • [44] Anitha, P, Lavanya P, Anbarasu A, Ramaiah S, Molecular docking study of catechins compounds from Camellia sinensis against UPPS in Staphylococcus aureus. International Journal for Computational Biology 3(2) (2014) 03-09
  • [45] Tsaioun K, Bottlaender M, Mabondzo A, Alzheimer's Drug Discovery Foundation. ADDME-Avoiding drug development mistakes early: central nervous system drug discovery perspective. BMC Neurol. 9(1) (2009) S1
  • [46] Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM, Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx 2(4) (2005) 554-557
  • [47] Hurst S, Loi CM, Brodfuehrer J, El-Kattan A, Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opin Drug Metab Toxicol. 3(4) (2007) 469-489
  • [48] Guengerich FP, Cytochromes P450, drugs, and diseases. Molecular Intervention 3 (2003) 194-204
  • [49] [49] Nuri THM, Ming LC, Papaya leaves juice as an alternative treatment for dengue fever. J App Pharm Sci. 6(03) (2016) 172-173
  • [50] Frimayanti N, Chee CF, Zain SM, Rahman NA, Design of new competitive dengue ns2b/ns3 protease inhibitors - A computational approach. Int J Mol Sci. 12 (2011) 1089-1100
  • [51] Heh CH, Othman R, Buckle MJ, Sharifuddin Y, Yusof R, Rahman NA. Rational discovery of dengue type 2 non-competitive inhibitors. Chem Biol Drug Des. 82 (2013) 1-11
  • [52] de Sousa LR, Wu H, Nebo L, Fernandes JB, da Silva MF, Kiefer W, et al. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies. Bioorg Med Chem. 23(3) (2014) 466-70
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.